An unmet medical need
Non-alcoholic steatohepatitis (NASH) is an advanced form of fatty liver disease that is expected to become the major cause of liver transplantation in the US by 2025. There is an enormous unmet medical need to treat the disease because of its high prevalence and lack of treatment options: there are currently no approved therapeutics for NASH.
Over 25% of adults worldwide have non-alcoholic fatty liver, and 10-30% of these people will progress to the more serious disease, NASH. Beyond lifestyle changes, there are no FDA approved therapeutic treatments for NASH.
We have a novel therapeutic approach to NASH based on a new understanding of disease-causing signalling pathways in the liver. Our approach reduces all 3 hallmarks of disease:
- fat accumulation
- fibrosis (liver scarring)
- inflammation
The project is currently supported by the Research Council of Norway, Novo Nordisk Foundation, and UiT – The Arctic University of Norway. Upon generation of proof-of-concept data, we plan to continue pre-clinical and clinical development through a spin-off company. We are seeking collaborations with the right partners to bring the project forward into pre-clinical and clinical development, including:
- industry collaborations and partnerships
- investors
Partners and collaborators
Contact information
Les om andre prosjekter:
Thyroid Assist
– A novel decision support aid tool (DST) for optimal levothyroxine dosage after thyroidectomy About the technology Levothyroxine is a necessary synthetic …
FiRsT – Optical microscope calibration targets
About the technology New and advanced label-free and super resolution microscopes and nanoscopes have emerged, and their characterization is becoming more demanding. …
Nanospacer
– Bringing nanofluidic technology to the people About the technology The Nanospacer is a specially designed microscope coverslip that allows nanoscale particle …
SPICE: Sea sPray ICE prediction model
A tool that predicts ice amount and distribution on marine structures About the technology Due to climate changes the Arctic marine territories …
Novel platform for live-imaging of cells in action
CYMOPLIVE – Cyto-Motility and Cyto-Plasticity in Vitro Live-Cell Assay About the technology Cymoplive is a platform that allows us to study cells …